HomeTOP STORIESAmylyx jumps on acquisition of Eiger’s GLP-1 drug Amylyx jumps on acquisition of Eiger’s GLP-1 drug By pvadmin July 10, 2024 FacebookTwitterPinterestWhatsApp [#item_full_content] Previous articleCVRx plunges, Sight Sciences jumps on proposed Medicare rate changesNext articleRelease of Kevin Costner’s Next ‘Horizon’ Film Is Canceled latest articles E2open targets FY 2026 subscription revenue of $525M-$535M amid operational enhancements Starbucks outlines accelerated rollout of updated service model to 2,000 stores by fiscal year-end Rogers corporation outlines Q2 2025 growth targets amid cost savings and tariff mitigation Vicor outlines growth in licensing revenues and advanced product development for 2025 The Six Triple Eight: Black, Female Soldiers Honored for World War II Success Floridians Are Getting Glimpses of What Aggressive Immigration Enforcement Looks Like explore more E2open targets FY 2026 subscription revenue of $525M-$535M amid operational enhancements Starbucks outlines accelerated rollout of updated service model to 2,000 stores by fiscal year-end Rogers corporation outlines Q2 2025 growth targets amid cost savings and tariff mitigation Vicor outlines growth in licensing revenues and advanced product development for 2025 The Six Triple Eight: Black, Female Soldiers Honored for World War II Success Floridians Are Getting Glimpses of What Aggressive Immigration Enforcement Looks Like
